CONNECT WITH US:
Nov 28, 2018 12:02 JST
Novotech CRO Announces 41 Clinical Staff and 81 Projects in South Korea
SYDNEY, Nov 28, 2018 - (ACN Newswire) - Asia-Pacific specialist CRO Novotech announced today that clinical staff numbers in its Seoul, South Korea centre are now at 41, with 81 clinical research projects now completed. The Novotech South Korea success is largely fueled by demand for a regional CRO with international accreditation and reputation, combined with local knowledge, partnerships and expertise.
Novotech now has 10 strategic collaborations with hospitals and research institutions in the region, and 11 offices across the Asia-Pacific region. South Korea is home to 49 million people of which 83.2% reside in urban centres. The average timeline for regulatory and IRB approval is 4-5 months.
Novotech's capabilities in South Korea are further supported by powerful partnerships with leading hospitals and medical facilities including:
The Asan Medical Centre - the largest medical institution in Korea with a total of 2,704 beds occupying about 85,000 square meters. On an average day the hospital has 11,862 outpatients, 2,557 inpatients, and 309 emergency patients, and performs about 63,791 highly sophisticated surgeries per year.
SCI-Consortium (SCIC) - a network of clinical trial centres comprising four of South Korea's leading hospitals: Yonsei University Health System (Severance Hospital and Gangnam Severance Hospital), The Catholic University of Korea St Mary's Hospital and Inha University Hospital. The network provides clinical trial access to over 1,500 investigators, almost 6,000 hospital beds and more than seven million patients per year.
One of the SCIC's key strengths is its clinical trial data system with more than ten million de-identified records. Its vast database provides easy identification of potential eligible patients, allowing much faster clinical trial recruitment. At present, the SCIC has over 30,000 active patients enrolled in clinical studies.
Novotech CEO Dr John Moller said Novotech has dedicated clinical experts within our South Korean hospital and research facilities partners to support and prioritise rapid clinical processes for Novotech biopharma clients.
He said there are many compelling reasons to consider South Korea for clinical research:
- Large patient population
- Strong and efficient regulatory environment
- Increasing use of English among the population
- World-class technological infrastructure
- Few competing trials
- Highly qualified and educated medical professionals
- Low operational costs
"Our partnership relationships enable a more comprehensive understanding of local regulatory changes, access to leading PIs, strong site connections, and productive patient populations to deliver success for our clients within timelines and budgets," Dr Moller said.
"The Novotech team is well positioned across the region to access the more than 1.4 billion people living in urban areas, which is a key factor in the decision by sponsors to include the Asia-Pacific in their global studies."
About Novotech -
Established in 1996 with headquarters in Sydney, Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech also has worldwide reach through the company's network of strategic partners.
For RFP enquiries: Please fill out the form available at www.novotech-cro.com/contact-us-0
For Media enquiries:
Susan Fitzpatrick-Napier, AU: +61 2 8218 2144
USA: +1 415 951 3228, ASIA: +65 3159 3427
Copyright ©2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Fujitsu Launches 14 New Models of Enterprise Notebooks, Tablets and Workstations Optimized for Remote Work
May 26, 2020 11:10 JST
Fujitsu Develops AI-Video Recognition Technology to Promote Hand Washing Etiquette and Hygiene in the Workplace
May 26, 2020 10:34 JST
Mitsubishi Motors Joins OPEN COVID-19 DECLARATION
May 26, 2020 09:34 JST
Tokyo Metropolitan Government to trial 5G Antenna-equipped Smart Poles in Cooperation with Sumitomo Corporation and NEC
May 25, 2020 10:44 JST
Mazda Begins Providing, Virtual Racing Car, Mazda RX-Vision GT3 Concept Online
May 22, 2020 14:26 JST
'e5 Consortium' Established to Promote Zero-Emission Electric Vessel
May 21, 2020 15:34 JST
TOYOTA GAZOO Racing Decides Not to Participate in 2020 Edition of Nurburgring 24 Hours
May 21, 2020 14:19 JST
Fujitsu RunMyProcess Drives Next Phase of Digital Transformation in Business Processes with DigitalSuite ProcessModeler
May 21, 2020 09:00 JST
MHPS Captures Global Gas Turbine Market Share Leadership Again
May 20, 2020 10:09 JST
Hitachi Awarded Contract to Supply, Install 300 Lifts at HDB Blocks in Singapore
May 19, 2020 11:57 JST
DENSO, Global Mobility Service to Support Delivery of COVID-19 Test Kits in Indonesia
May 18, 2020 17:36 JST
Eisai to Launch New Selbelle Premium Tablets and New Selbelle Premium Fine Granules
May 18, 2020 13:33 JST
Hitachi to Provide $1 Million in Loans through Kiva to Businesses in Need around the Globe, Affected by the Spread of the COVID-19
May 18, 2020 13:24 JST
Toyota's Adjustments to Domestic Production in June 2020 (as of May 15)
May 15, 2020 17:01 JST
Transgene and NEC Demonstrate High Accuracy of AI-based Neoantigen Prediction for the Design of Individualized Cancer Vaccine TG4050
May 15, 2020 14:10 JST
Fujitsu and Accenture Collaboration Accelerates Reliable Blockchain Interoperability
May 15, 2020 10:11 JST
Mazda Releases FY March 2020 Full Year Financial Results
May 14, 2020 17:01 JST
Fujitsu Sets Out the 'Fujitsu Technology and Service Vision 2020'
May 14, 2020 15:53 JST
Notice of Agreement for the Merger through Absorption (Simplified Absorption-type Merger) of a Consolidated Subsidiary of Fujitsu Limited
May 14, 2020 15:46 JST
Eisai to Present Data on Oncology Pipeline and Products at ASCO20 Annual Meeting
May 14, 2020 09:22 JST
More Latest Release >>
Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study
April 29 2020 21:00 JST
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
April 28 2020 19:00 JST
Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity
April 08 2020 18:00 JST
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials
March 20 2020 20:30 JST
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea
March 06 2020 22:00 JST
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO
January 21 2020 10:40 JST
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research
July 11 2019 11:00 JST
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO
May 31 2019 07:00 JST
Novotech CRO strengthens South Korean Clinical Capabilities, partners with 2 Major Hospitals
April 18 2019 04:00 JST
Novotech CNS USA Appoints Dr Robert Malone to its Washington, DC BioDesk
March 25 2019 18:00 JST
More Press release >>